Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Nigeria
Nigeria: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 62.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Nigeria, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Nigeria is 62.0%, measured in 2025.
Compared with earlier readings it is down 1.6% on the previous year and up 72.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Nigeria peaked at 64.0% in 2019 and was at its lowest, 0.0%, in 2008.
That places Nigeria 144th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 26.1% | 0.0% | 64.0% | 10 |
| 2020s | 58.5% | 48.0% | 63.0% | 6 |
Countries ranked near Nigeria
- 141 Benin 64.0% compare
- 142 Democratic Republic of Congo 63.0% compare
- 142 Afghanistan 63.0% compare
- 144 Marshall Islands 62.0% compare
- 144 Laos 62.0% compare
- 147 North Macedonia 60.0% compare
More health data for Nigeria
- Heat deaths vs projected death rates 1,301 (2090)
- Un projection of annual infant deaths 257,921 (2100)
- Deaths in armed conflicts by country 726 (2026)
- Deaths in armed conflicts by region 726 (2026)
- Age population, age 25, male, interpolated 2.03 million (2025)
- Age population, age 25, female, interpolated 1.96 million (2025)
- Age population, age 24, male, interpolated 2.13 million (2025)
- Age population, age 24, female, interpolated 2.06 million (2025)
- Age population, age 23, male, interpolated 2.23 million (2025)
- Age population, age 23, female, interpolated 2.15 million (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Nigeria?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Nigeria was 62.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Nigeria?
- The highest recorded value was 64.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Nigeria?
- The lowest recorded value was 0.0% in 2008.
- How does Nigeria rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Nigeria ranks 144th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Nigeria?
- Over the last ten years it is up 72.2%. The long-run trend across the full record is volatile.
- Where does this Nigeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).